Literature DB >> 8452532

Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

N V Bogatcheva1, A V Vorotnikov, K G Birukov, V P Shirinsky, N B Gusev.   

Abstract

Smooth muscle caldesmon was phosphorylated by casein kinase II, and the effects of phosphorylation on the interaction of caldesmon and its chymotryptic peptides with myosin and tropomyosin were investigated. The N-terminal chymotryptic peptide of caldesmon of molecular mass 27 kDa interacted with myosin. Phosphorylation of Ser-73 catalysed by casein kinase II resulted in a 2-fold decrease in the affinity of the native caldesmon (or its 27 kDa N-terminal peptide) for smooth muscle myosin. At low ionic strength, caldesmon and its N-terminal peptides of molecular masses 25 and 27 kDa were retarded on a column of immobilized tropomyosin. Phosphorylation of Ser-73 led to a 2-4-fold decrease in the affinity of caldesmon (or its N-terminal peptides) for tropomyosin. Thus phosphorylation of Ser-73 catalysed by casein kinase II affects the interaction of caldesmon with both smooth muscle myosin and tropomyosin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452532      PMCID: PMC1132292          DOI: 10.1042/bj2900437

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Interaction of smooth muscle caldesmon with S-100 protein.

Authors:  E V Skripnikova; N B Gusev
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

2.  Phosphoprotein kinases from rat liver cytosol.

Authors:  S Matsumura; M Takeda
Journal:  Biochim Biophys Acta       Date:  1972-11-10

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Phosphorylation of caldesmon by protein kinase C.

Authors:  H Umekawa; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

5.  Reversible phosphorylation of smooth muscle myosin, heavy meromyosin, and platelet myosin.

Authors:  J R Sellers; M D Pato; R S Adelstein
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

6.  Prediction of a triple-stranded coiled-coil region in tropomyosin-troponin T complex.

Authors:  K Nagano; S Miyamoto; M Matsumura; I Ohtsuki
Journal:  J Theor Biol       Date:  1982-02-21       Impact factor: 2.691

7.  Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein.

Authors:  T Spector
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

8.  Amino acid sequence of chicken gizzard beta-tropomyosin. Comparison of the chicken gizzard, rabbit skeletal, and equine platelet tropomyosins.

Authors:  C Sanders; L B Smillie
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin.

Authors:  K Sobue; Y Muramoto; M Fujita; S Kakiuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

Review 10.  The thin filaments of smooth muscles.

Authors:  S B Marston; C W Smith
Journal:  J Muscle Res Cell Motil       Date:  1985-12       Impact factor: 2.698

View more
  9 in total

Review 1.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

2.  Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.

Authors:  Z Wang; H Jiang; Z Q Yang; S Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Alignment of caldesmon on the actin-tropomyosin filaments.

Authors:  T S Tsuruda; M H Watson; D B Foster; J J Lin; A S Mak
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

4.  Identification of functioning regulatory sites and a new myosin binding site in the C-terminal 288 amino acids of caldesmon expressed from a human clone.

Authors:  P A Huber; C S Redwood; N D Avent; M J Tanner; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

5.  Location of smooth-muscle myosin and tropomyosin binding sites in the C-terminal 288 residues of human caldesmon.

Authors:  P A Huber; I D Fraser; S B Marston
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Location and functional characterization of myosin contact sites in smooth muscle caldesmon.

Authors:  A V Vorotnikov; S B Marston; P A Huber
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Phosphorylation of caldesmon by smooth-muscle casein kinase II.

Authors:  C Sutherland; B S Renaux; D J McKay; M P Walsh
Journal:  J Muscle Res Cell Motil       Date:  1994-08       Impact factor: 2.698

Review 8.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

9.  Caldesmon mRNA splicing and isoform expression in mammalian smooth-muscle and non-muscle tissues.

Authors:  A M Payne; P Yue; K Pritchard; S B Marston
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.